Ensysce Biosciences, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for ENSC, updated each market day.
ENSC AI Sentiment
AI predicts Ensysce Biosciences, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Ensysce Biosciences, Inc. Common Stock
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Sector
Exchange
Market Cap
$4,490,464
Cap Tier
Employees
10
Headquarters
LA JOLLA, CA
Listed Since
July 1, 2021
Website
ENSC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ENSC Volatility
Ensysce Biosciences, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
